Should you buy this stock after sales rose 20% in Q3?

Is a 20% rise in sales the beginning of big things for this company?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Third quarter results released today for speciality chemicals maker Croda (LSE: CRDA) saw sales jump a full 20.1% year-on-year to hit £315m. Unfortunately, management was very upfront about the fact that “with over 95% of sales outside the UK, this largely reflected favourable currency translation, with the impact of weaker sterling increasing sales by 17.6%.”

Stripping out the effects of the weaker pound, constant currency sales did rise 2.5% year-on-year due to the positive effects of an acquisition in Croda’s crop care division. However, core underlying sales dropped 2.5% on the back of falling sales of a major generic pharmaceutical ingredient.

Sales compressing is never a good sign and will be worth watching in the coming quarters. But, if underlying sales return to growth then Croda becomes very attractive. A major reason is that the company is well diversified by designing chemicals for everything from haircare, lipstick and sunscreen to seed treatments and environmentally-friendly paint coatings.

Developing and selling these products is also a very capital light business, which produces significant free cash flow. And, a cost-conscious management team and increasing sales of patented products allowed operating margins to improve to 25.7% in H1.

The impressive cash generated by these margins and tight control over capex allow Croda to make targeted acquisitions without resorting to high leverage. At the end of July the company’s net debt-to-EBITDA ratio was only 1.3, a very healthy level for such a cash generative business. This is allowing dividends to increase substantially, although a long rally in share prices means they only yield 2%. Croda is certainly an attractive company, and I believe the shares are worth following in the coming quarters.

Worth a look?

While Croda’s products focus on retail applications, another of the FTSE’s leading industrial firms, Elementis (LSE: ELM), concentrates on industrial applications for oil rigs, cargo ships and construction materials. Elementis has been hit hard by the downturn in the oil & gas industry, with revenue from this key segment down 26% in the first half of the year.

This dramatic fall in sales drove overall group revenue down by 7% year-on-year and led to operating margins collapsing from 19% to 15%. A decrease in oilfield activity isn’t the only headwind facing Elementis as the strong US dollar has negatively impacted sales in its chromium division and forced the company to issue a profit warning in June.

That said, its core business is quite impressive. Its operations still spin off significant cash, which management has no qualms about returning to shareholders due to having no debt. With net cash at the end of June standing at $37.5m, the company was able to maintain interim dividends even as earnings fell.

The twin headwinds facing Elementis, a struggling oil & gas sector and strong US dollar, aren’t about to stop any time soon. However, with a great underlying business, shares trading at a relatively sane level and dividends already yielding 3.3%, now could be the time for contrarian investors to take a closer look.

Ian Pierce has no position in any shares mentioned. The Motley Fool UK has recommended Elementis. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Caucasian man making doubtful face at camera
Dividend Shares

Will the Diageo share price crash again in 2026?

The Diageo share price has crashed 35.6% over one year, making it one of the FTSE 100's worst performers in…

Read more »

Investing Articles

Is Alphabet still one of the best shares to buy heading into 2026?

The best time to buy shares is when other investors are seeing risks. Is that the case with Google’s parent…

Read more »

Investing Articles

Could the Barclays share price be the FTSE 100’s big winner in 2026?

With OpenAI and SpaceX considering listing on the stock market, could investment banking revenues push the Barclays share price higher…

Read more »

Investing Articles

Will the Nvidia share price crash in 2026? Here are the risks investors can’t ignore

Is Nvidia’s share price in danger in 2026? Stephen Wright outlines the risks – and why some might not be…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Growth Shares

I asked ChatGPT how much £10,000 invested in Lloyds shares 5 years ago is worth today? But it wasn’t very helpful…

Although often impressive, artificial intelligence has its flaws. James Beard found this out when he used it to try and…

Read more »

Portrait of pensive bearded senior looking on screen of laptop sitting at table with coffee cup.
Investing Articles

Did ChatGPT give me the best FTSE stocks to buy 1 year ago?

ChatGPT can do lots of great stuff, but is it actually any good at identifying winning stocks from the FTSE…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

Who will be next year’s FTSE 100 Christmas cracker?

As we approach Christmas 2025, our writer identifies the FTSE 100’s star performer this year. But who will be number…

Read more »

Businessman with tablet, waiting at the train station platform
Investing Articles

I asked ChatGPT for an 8%-yielding passive income portfolio of dividend shares and it said…

Mark Hartley tested artificial intelligence to see if it understood how to build an income portfolio from dividend shares. He…

Read more »